Discovery & Development

Are all antibiotics doomed to eventual impotence? New work from Oxford could change the game by defeating resistance itself.

Thorben Seeger wants to democratize the data held by the world’s leading genomic institutions. But what exactly does he mean by “democratize”?

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.

The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

Enter the world of immersive therapeutics – where VR is being explored as an alternative to traditional medicines for pain.

Work by an international team in Japan has found a new and effective way to attack cancer inside the body.

Find out how nanotechnology can overcome challenges in drug delivery to the eye.

We explore the potential of mRNA as therapeutics and the challenges associated with analysis and sequencing.

With so many new dosage forms being seen in pharma, a problem is emerging: the need for novel excipients. Watch our video to learn more.

We sit down to interview Louise Modis, Chief Scientific Officer at Mogrify, UK, about her career and role at the company.